PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2017Chemical Society Reviews814 citations

Drug delivery by supramolecular design

View Full Paper
MWMatthew J. WebberRLRóbert Langer

Key Points

Key points are not available for this paper at this time.

Abstract

The rational design of drug delivery approaches leveraging supramolecular chemistry (i.e., "chemistry beyond the molecule") has garnered significant interest in recent years toward improving therapeutics. By using specific, dynamic, and tunable non-covalent interactions, engineered approaches to drug delivery can be realized. Certain benefits to this approach are molecular-level control of composition, improved routes for incorporating and targeting drugs, and new strategies to create delivery devices that respond to a variety of physiologic indicators. Some of the most recognizable supramolecular motifs - macrocyclic host-guest complexes - afford logical application to drug delivery in using drug as guest. The use of supramolecular motifs may further give rise to materials for the controlled encapsulation and release of therapeutics. Furthermore, given the majority of supramolecular motifs in water are directed by hydrophobic interactions, cooperative delivery strategies can be realized. The modularity of supramolecular interactions also facilitates opportunities to combine multiple drugs within one delivery platform, as well as the facile incorporation of targeting units. In sum, supramolecular design offers ample opportunity to improve the precision of pharmaceutical practice. In the context of clinical translation, features of supramolecular design may prove additionally advantageous, specifically in enabling quantitative drug loading, molecularly discrete delivery devices, and a priori knowledge of carrier degradation and clearance mechanisms. As such, the design opportunities afforded by supramolecular chemistry will play a vital role in the future of the drug delivery field.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Webber et al. (2017) studied this question.

synapsesocial.com/papers/6a0872e10df715653be8ab7chttps://doi.org/10.1039/c7cs00391a
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Supramolecular Assemblies of Nucleoside Phosphocholine Amphiphiles2004 · 124 citations
  2. 2Supramolecular Nanofibrils Inhibit Cancer Progression In Vitro and In Vivo2014 · 40 citations
  3. 3The enzyme as drug: application of enzymes as pharmaceuticals2003 · 284 citations
  4. 4Supramolecular Chemistry—Scope and Perspectives Molecules, Supermolecules, and Molecular Devices (Nobel Lecture)1988 · 3,813 citations
  5. 5Enhanced potency of cell-based therapy for ischemic tissue repair using an injectable bioactive epitope presenting nanofiber support matrix2014 · 27 citations